New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...
Morning Overview on MSN
Scientists found a hidden pocket on a cancer protein that drugs were never able to grip, opening a path to a new class of precise tumor blockers
Researchers have mapped a previously unseen drug-binding pocket on PKMYT1, a kinase tied to cancer cell division, using X-ray ...
A new era in the treatment of deadly pancreatic cancer was heralded by scientists this week, thanks to research by the ...
A new cancer drug helps the immune system detect hidden tumors and offers real clinical hope to patients with advanced-stage ...
Investors have bet new drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller.
The FDA has given some patients early access to the drug, daraxonrasib. A study being presented at an oncology conference in ...
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...
A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...
Health and Me on MSN
Ovarian cancer: UK NHS rolls out first major drug in over 20 years
The last major NHS treatment introduced for patients with ovarian cancer was the rollout of liposomal doxorubicin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results